More Paradigm Biopharmaceuticals Ltd. news
Paradigm Biopharmaceuticals Ltd.ASX: PAR

S&P DJI Announces June 2020 Quarterly Rebalance

Jun 11, 2020 at 10:36 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd.

Filed with ASX · Jun 11, 2020 at 10:36 PM EDT · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-june-2020-quarterly-rebalance-89

Paradigm Biopharmaceuticals Ltd. on 6ix

Story so far

  • S&P DJI Announces March 2019 Quarterly RebalanceMar 8, 2019

Earlier from Paradigm Biopharmaceuticals

  • Block trade to institutional investorsMay 12, 2020
  • EAP treatment completed and Orphan Status achieved for MPS-IApr 30, 2020
  • Reinstatement to Official QuotationApr 8, 2020
  • Paradigm completes $35m raisingApr 7, 2020
  • Paradigm Reports Very Encouraging Real World DataApr 6, 2020

Later from Paradigm Biopharmaceuticals

  • New financial year updateJul 15, 2020
  • EAP - 65% pain reduction in 10 OA patients in usaJul 29, 2020
  • Quarterly Activities ReportJul 31, 2020
  • MPS receives critical approvals and feedback from agenciesAug 10, 2020
  • Appendix 4E and 2020 Annual ReportAug 27, 2020
All Paradigm Biopharmaceuticals news releases↗

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer